Creative Medical Technology Holdings Inc (CELZ)

[Stock_Goodies]

Response I received from company:

"Our clinical trial at UCLA is ongoing. All the patients have received the procedure and we are now tracking them for 12 months following the procedure. The Institutional Review Board (IRB) has reported the procedure is safe. We also have colleagues in France that ran the same trial and published the results. They also determined the procedure is safe and 75% of the patients showed significant improvements.

I can't go into the number of procedures because we have not reported it to the public. You will most likely see that number in the future filings. That said, there has been a much less effective procedure (P-Shot) that has been performed on thousands of patients using platelet-rich plasma. Bone marrow is significantly more potent versus plasma.

Dr. Alex Gershman is our physician in Los Angeles. He is performing the procedure daily."


Trial will be completed in the next few months, and the procedure is already being performed DAILY. Excited to see what revenues are looking like on Q1 fins next week $$$